Targeted drug shows promising ability in treating rare head and neck cancers
Experts at University of Michigan Health Rogel Cancer Center have conducted the first study evaluating the effectiveness of a targeted drug for patients with salivary gland cancers (SGC).
Mar 1, 2024
0
0